Pope Leo XIV needs surgery to remove a lung nodule. The Vatican announced this yesterday. Retail traders immediately checked if there's a papal ETF they can short.
The Pope plays tennis weekly. He swims at Castel Gandolfo. He has no prior health issues. He's more physically active than every single person who will panic-sell their portfolio because they think this somehow affects the semiconductor supply chain.
Somewhere right now a guy named Derek is typing "pope lung surgery stock market impact" into Google. Derek will find three articles. Two will be from 2005. One will be a Reddit thread where someone argues this is bullish for medical device manufacturers. Derek will buy calls on Medtronic. Derek will lose money. The Pope's surgery will have nothing to do with it.
The nodule is being removed as a precaution. That's what nodule removal is. You find something that shouldn't be there and you take it out. This is not complicated. But five hedge fund analysts are already building a PowerPoint about European healthcare exposure and Catholic demographic trends. Their thesis will be wrong. Their fonts will be inconsistent. Their managing director will not read past slide three.
The Pope will recover. He'll go back to tennis. He'll swim at the summer retreat. The markets will do whatever they were going to do anyway, which is absolutely nothing related to papal health or lung nodules or weekly tennis schedules.
Derek's calls expire worthless on Friday.
Photo by on Unsplash
Leave a Comment